What does this LOINC code represent?

This LOINC code identifies a lab observation, measurement, question, or clinical concept in a standardized format.

Is this enough to understand my test result?

No. The code identifies the test or observation, but the interpretation depends on the actual result, reference range, and clinical context.

LOINCActiveBoth

LOINC Code 99107-5: Stimulants drug panel Screen (U)

Name: LOINC Code 99107-5: Stimulants drug panel Screen (U)
Creator: HealthAssure Clinical Team
Published: 2026-05-21T09:00:33.064Z

99107-5 is a LOINC code used to identify Stimulants drug panel Screen (U) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Stimulants drug panel. It is commonly used with the system or sample type Urine.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Stimulants drug panel. It is commonly used with the system or sample type Urine.

When is it used?

Used in lab systems, EHRs, and clinical data exchange.
May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
Status: ACTIVE
Order vs observation: Both
Panel type: Panel
Method: Screen

What it does not mean

The code identifies the observation or test, not the actual result.

Key facts

Stimulants drug panel - Urine by Screen method

Stimulants drug panel

This panel aides in the determination of compliance or identify illicit stimulant drug use. The panel detects stimulants which stimulate the central nervous system activity and, in part, suppress the appetite. Amphetamine and methamphetamine are also prescription drugs used in the treatment of narcolepsy and attention-deficit disorder/attention-deficit hyperactivity disorder (ADHD). Methylphenidate is another stimulant used to treat ADHD. Phentermine is indicated for the management of obesity. All of the other amphetamines (e.g., methylenedioxymethamphetamineMDMA) are Drug Enforcement Administration (DEA) scheduled Class I compounds. Physiological symptoms associated with very high amounts of ingested amphetamine or methamphetamine include elevated blood pressure, dilated pupils, hyperthermia, convulsions, and acute amphetamine psychosis. If a stimulant or its corresponding metabolite is identified (present), it indicates that the patient has used the respective stimulant in the recent past (typically 1-3 days). The absence of the expected stimulant or its metabolites may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted or adulterated urine, or limitations of testing. The concentration of the drug must be greater than or equal to the cutoff to be reported as present.

DRUG/TOXICOLOGY; Drugs; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Stimul; Stimulant; UA; UR; Urn

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Stimulants drug panel Screen (U)Stimulants drug panel - Urine by Screen methodStimulants drug panel Ur ScnStimulants drug panelPANEL.DRUG/TOXStimulants drug panel, Urine-

Frequently asked questions

Code details

Code99107-5

SystemLOINC

Display nameStimulants drug panel Screen (U)

DescriptionStimulants drug panel

Short nameStimulants drug panel Ur Scn

ComponentStimulants drug panel

Property-

TimingPt

System (specimen)Urine

Scale-

MethodScreen

ClassPANEL.DRUG/TOX

StatusACTIVE

Order/ObservationBoth

Flags

BillableNo

Valid clinical useNo

Source

SourceLOINC

Version2.82

Releasemain

First released2.72

Last changed2.72

Consumer names

Stimulants drug panel, Urine

Part names

Stimulants drug panel-PtUrineScreenPoint in time (spot)Toxicology screen

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.